| Tue, Dec 8, 2009 | | • | FDA: Gilead cystic fibrosis studies flawed
at bizjournals.com (Tue 2:05pm)
| | • | New review questions benefit of Roche drug Tamiflu
at Reuters (Tue 2:00pm)
| | • | UPDATE - U.S. FDA questions studies of Gilead fibrosis drug
at Reuters (Tue 12:39pm)
| | • | Gilead set to benefit from HIV guidelines
at FT.com (Tue 6:00am)
| | Mon, Dec 7, 2009 | | • | Don't Touch These 3 Huge Value Traps
at Motley Fool (Mon, Dec 7)
| | Thu, Dec 3, 2009 | | • | The Stocks With the Most Potential
at Motley Fool (Thu, Dec 3)
| | • | Prospecting for Winning Biotechs: Gilead Sciences
at Motley Fool (Thu, Dec 3)
| | • | [$$] Gilead Shares Should Get Shot in Arm
at Barrons.com (Thu, Dec 3)
| | • | Gilead-Glaxo Deal Targets Asia
Zacks.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | Ten Minutes That Mattered: NetApp's Georgens
at Forbes.com (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | Drug Firms Get A Boost On World AIDS Day
at Forbes.com (Tue, Dec 1)
| | • | The Top 15 AIDS Drugs
at Forbes.com (Tue, Dec 1)
| | • | AIDS: Still a Problem, Still Big Business for Pharma
at Minyanville.com (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | Lightning Round OT: Yamana Gold, 3Com and More
at CNBC (Mon, Nov 30)
| | • | Swine flu still down in US but 198 children dead
at Reuters (Mon, Nov 30)
| | • | WHO issues new recommendations for HIV patients
at Reuters (Mon, Nov 30)
| | • | Drugs: Cost is the highest barrier for treatments
at FT.com (Mon, Nov 30)
| | • | Biotech Calendar: Key Dates for December
at TheStreet.com (Mon, Nov 30)
| | • | China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO
at Seeking Alpha (Mon, Nov 30)
| | Fri, Nov 27, 2009 | | • | A Mostly Meaningless FDA Approval
at Motley Fool (Fri, Nov 27)
|
Add GILD News to My Yahoo!:
 
| |
|
0.50% Nasdaq 
0.12 (0.26%) 
Headlines
